This legislation aims to establish a new National Institute for Biomedical Research and Development, focusing on enhancing the accessibility and affordability of medical products, including drugs and devices. The primary goal is to prioritize public health needs while fostering innovation in the biomedical sector. Key provisions include the creation of a comprehensive research and development program overseen by the Institute's Director.